adminPharmaceuticals factory had improved and the business was close to viability. But the increased production had not been absorbed in the market resulting in output outstripping demand.
“Based on the lower than expected sales along with the high costs of labour and other fixed essential costs, this manufacturing business has been assessed as unviable without further capital input and a longer investment horizon,” said in a note to shareholders yesterday.
“The board has taken a decision to close this business as soon as possible to minimise further losses. There is however a possibility that the business could be sold although there are no firm offers or advanced discussion in this regard. Should this situation change, shareholders will be advised of the developments. MedTech said upon closure of ZimPharm, the group will primarily focus on distribution.
Analysts say Zimbabwe’s pharmaceutical industry in terms of manufacturing had its inefficiencies exposed by the global environment. Emerging from a decade of decline, the equipment was old and technology had moved on. Currently, India is very much at the centre of the industry.
Online Reporter
- Herald
- June 4, 2026
- 19 views
DeliverED! . . . Zim lands UN Security Council seat . . . President hails diplomatic milestone
Innocent Madonko and Zvamaida Murwira-Herald Reporters PRESIDENT Mnangagwa has described as a “significant diplomatic milestone”, Zimbabwe’s huge victory which secured the country a non-permanent seat on the United Nations Security…
